Series of lectures (face to face) covering retina, cataract and cornea
Date: 14/03/2023 (AEDT)
Venue: Level 2, 741 Pacific Highway Gordon , NSW, 2072
Provider: The Gordon Eye Surgery
Contact: Donna Glenn, [E] d.glenn@gordoneye.com.au, [P] 0294181488
Learning Objectives
- Understand the medical use and applications for the use of Vabysmo and its use in treating and benefits to patients
- Understand the practical aspects to a patients journey when having cataract surgery
- Review (via video) the steps involved in the cataract surgery process to be able to reassure and educate patients and answer their FAQs
- Understand which patients require referral for keratoconus review with an ophthalmologist
- Understand treatment options for children with karatoconus
- Understand results of keratoconus treatment
Max CPD hours awarded: 1.5
Session Information
| Name |
|---|
| Retina - Update on Faricimab (Vabysmo), the newly approved drug for AMD and DMO |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Cataract - Virtual Tour of the patients theatre journey for cataract surgery |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Cornea - Treatment of keratoconus in Children |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |